Aguilar David, Goldhaber Samuel Z, Gans Daniel J, Levey Andrew S, Porush Jerome G, Lewis Julia B, Rouleau Jean-Lucien, Berl Tomas, Lewis Edmund J, Pfeffer Marc A
Division of Cardiology, University of Texas Health Science Center, Houston, 77030, USA.
Am J Cardiol. 2004 Aug 1;94(3):337-9. doi: 10.1016/j.amjcard.2004.04.028.
During the Irbesartan Diabetic Nephropathy Trial, 1,387 participants with type 2 diabetes mellitus, hypertension, and nephropathy underwent serial electrocardiograms for the identification of Q-wave myocardial infarction (MI). During a mean follow-up of 2.5 years, 14 of 99 first nonfatal MIs in this group were clinically unrecognized, accounting for 14% of all first nonfatal MIs.